Resistance to malaria drug rings alarm bellsApril 8th, 2012 - 3:37 pm ICT by IANS
Washington, April 8 (IANS) Resistance to anti-malarial drug artemisinin in western Thailand is sending alarm bells ringing among global experts involved in controlling and eliminating the scrouge worldwide, a new study says.
Another study, also by Texas Biomedical Research Institute and their Thai collaborators has indentified a major region of the malaria parasite genome tied to artemisinin resistance, raising hope that there may soon be effective molecular markers for monitoring the spread of resistance.
Malaria killed 655,000 people or over one per minute in 2010. Malaria deaths have declined by 30 percent over the past decade, because of effective control using treatment with combination therapies containing artemisinin, a plant-derived antimalarial drug developed in China, the journal Lancet reported.
Patients infected with malaria parasites who respond poorly to treatment have been observed in Cambodia, bringing forth a coordinated World Health Organization effort to eliminate the disease in this region, said a university statement.
From 2001 until 2010, the Texas Biomed team and collaborators studied 3,202 patients in clinics in Northwestern Thailand, 500 miles from the Cambodian focus, according to the journal Lancet.
Researchers observed a dramatic decline in the drug potency over that period. Further, by measuring drug potency in patients infected with genetically identical malaria parasites, they were able to show that the decline in potency results from the spread of resistance genes.
“Spread of drug resistant malaria parasites within Southeast Asia and overspill into sub-Saharan Africa, where most malaria deaths occur, would be a public health disaster resulting in millions of deaths,” said Texas Biomed’s Standwell Nkhoma, who led the study.
“The problem we have is that treatment with artemisinin-based drugs will promote spread of resistance, but there are no viable alternative treatment options in Southeast Asia,” said Nkhoma.
“Our group wanted to understand what genetic changes have occurred in these parasites,” said Texas Biomed’s Ian Cheeseman, who led the companion study, the journal Science reported.
“This study narrows the search to a region of the parasite genome containing around 10 genes. We haven’t yet found the precise changes involved, but we are getting close,” said Cheeseman.
- Drug-resistant Malaria spreads along Thai-Myanmar border - Apr 06, 2012
- Natural compounds could pave way for novel anti-malaria drugs - Mar 15, 2011
- Malaria parasite developing drug resistance in Cambodia - Jul 30, 2009
- New gene study paves way for more anti-malaria treatments - Oct 11, 2010
- New study could improve diagnosis and treatment of malaria - Sep 09, 2010
- Genes that aid antimalarial drug resistance identified - Apr 22, 2011
- Dispersing fungal spores over water kills malaria mosquito larvae - Feb 21, 2011
- Novel anti-malarial drug candidate discovered - Sep 03, 2010
- Scientists locate malaria parasites' Achilles heal - Apr 22, 2012
- Coming soon: Single-dose malaria drug - Sep 04, 2010
- New method may help fight drug-resistant malaria - Aug 03, 2010
- Largest clinical trial confirms new drug for worldwide malaria treatment - Nov 07, 2010
- Malaria developing resistance to effective drugs, warn scientists - May 29, 2009
- India-origin scientist's findings may hold key to novel malaria vaccines - Oct 22, 2010
- Modified bone drug kills malaria parasite - Feb 28, 2012
Tags: alarm bells, artemisinin, biomedical research institute, combination therapies, dramatic decline, drug potency, global experts, journal lancet, malaria deaths, malaria drug, malaria parasite, malaria parasites, northwestern thailand, organization effort, public health disaster, resistance genes, resistant malaria, scrouge, western thailand, world health organization